Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01
Published April 3, 2024 · Recall initiated: March 4, 2024
Summary
FDA records drug Class I recall D-0429-2024, published April 3, 2024 and initiated March 4, 2024. Recalling firm: Par Sterile Products LLC; Status: Ongoing; Reported quantity: 466 vials; Lot: Lot#: 57014; Exp, 04/30/2024. Class I means a reasonable probability of serious adverse health consequences or death.
Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Presence of Particulate Matter.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Par Sterile Products LLC
- Distributor
- Nationwide in the USA
- Lot
- Lot#: 57014; Exp, 04/30/2024
- Risk classification
- Class I
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDATri-Lo-Sprintec (norgestimate and ethinyl estradiol) tablets USP - triphasic regimen, packaged in cartonApril 3, 2024
- FDAHimalayan Pain Relief Tea for Gout and HangoverApril 3, 2024
- FDAVCF Vaginal Contraceptive Film (nonoxynol-9, 28%), package in a carton with 9 single films, Distributed By:April 3, 2024
- FDAThe label reads, "Golden Sunrise Cold Pressured Juice Carrot, Orange, Pineapple, Lemon, Ginger & Turmeric 11April 3, 2024
- FDADivalproex Sodium Extended-release Tablets, USP 250 mg, Rx Only, 100 tablets, Manufactured by: AmnealApril 3, 2024
- FDAVasostrict (vasopressin in 5% Dextrose) Injection, 20 units per 100 mL (0.2 units per mL), 100 mL x 10 SingleJanuary 24, 2024
Questions about this recall
Was Treprostinil Injection, 20 mg/20 mL (1 mg/mL), For Subcutaneous or Intravenous Infusion Only, 20 mL Multiple-Dose Vial, Rx Only, Distributed by: Par Pharmaceutical, Chestnut Ridge, NY 10977. NDC: 42023-206-01 recalled?
Yes. FDA published recall D-0429-2024 on April 3, 2024. Reported hazard: Presence of Particulate Matter.
What should I do if I have this product?
Voluntary: Firm initiated · Letter